Autocrine S100B effects on astrocytes are mediated via RAGE

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Astrocytic protein S100B is implicated in various neurological conditions.
• The receptor for advanced glycation end products (RAGE) is expressed on astrocytes.
• Autocrine signaling pathways in astrocytes are not fully understood.

Purpose of the Study:

• To investigate the role of astrocytic S100B in autocrine signaling.
• To determine if S100B upregulates Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-alpha) expression in astrocytes via RAGE.
• To confirm the cell surface localization of RAGE in cultured astrocytes.

Main Methods:

• Immunofluorescence microscopy, flow cytometry, and Western blotting were used to confirm RAGE localization on astrocyte cell membranes.
• Enzyme-linked immunosorbent assay (ELISA) was employed to measure IL-6 and TNF-alpha secretion.
• Small interfering RNA (siRNA) targeting RAGE was used to knock down RAGE expression.

Main Results:

• S100B stimulation led to a concentration- and time-dependent increase in IL-6 and TNF-alpha secretion by cultured astrocytes.
• RAGE expression was confirmed at the cell surface membrane of astrocytes.
• RAGE siRNA effectively blocked the S100B-induced secretion of IL-6 and TNF-alpha.

Conclusions:

• Astrocytic S100B can induce autocrine inflammatory responses through RAGE.
• Targeting the S100B-RAGE pathway may offer therapeutic strategies for neurological disorders involving astrocyte activation.